Federal Register: FDA Establishes Special Controls for Implanted Overactive Bladder Neuromodulation Devices
September 10, 2026
September 10, 2026
WASHINGTON, Sept. 10 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device
The Food and Drug Administration (FDA) is classifying the implanted tibial electrical urinary continence device into class II. The special controls that apply to the . . .
* * *
Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device
The Food and Drug Administration (FDA) is classifying the implanted tibial electrical urinary continence device into class II. The special controls that apply to the . . .